The problem
A batch management change nobody wants to own
Batch numbering, material master structures and manufacturing execution data have to stay traceable, or a GxP audit becomes a problem. Most pharma companies inherit batch setups nobody fully documented.
Validation and test environments carry the same weight. If test data doesn't reflect real batch and material structures, the validation isn't testing what production will actually run.